Tech Company Financing Transactions
Thrive Earlier Detection Funding Round
Thrive Earlier Detection secured a $257 million Series B investment round on 7/30/2020. Investors included Casdin Capital, Section 32 and Bain Capital Life Sciences.
Transaction Overview
Company Name
Announced On
7/30/2020
Transaction Type
Venture Equity
Amount
$257,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance its test into a registrational trial and continue to work closely with key stakeholders to remove barriers to ensure timely access, including future reimbursement for CancerSEEK.
Company Information
Company Status
Acquired or Merged
Industry
Healthcare IT
Mailing Address
38 Sidney St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Thrive Earlier Detection Corp. is a healthcare company focused on incorporating earlier cancer detection into routine medical care to extend and save lives. Thrive is developing CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of disease that will serve as the core of its integrated cancer information offering.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/30/2020: dataPlor venture capital transaction
Next: 7/30/2020: Bright Peak Therapeutics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs